301 related articles for article (PubMed ID: 14982510)
1. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
[TBL] [Abstract][Full Text] [Related]
2. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
3. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
4. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma.
Micheletto C; Tognella S; Guerriero M; Dal Negro R
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582
[TBL] [Abstract][Full Text] [Related]
5. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
Micheletto C; Visconti M; Tognella S; Trevisan F; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
[TBL] [Abstract][Full Text] [Related]
6. [Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome].
Di Rienzo L; Artuso A; Cerqua N
Acta Otorhinolaryngol Ital; 2000 Oct; 20(5):336-42. PubMed ID: 11284261
[TBL] [Abstract][Full Text] [Related]
7. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
8. [Nasal polyps is not a homogenous pathology].
Arcimowicz M; Balcerzak J; Samoliński BK
Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
[TBL] [Abstract][Full Text] [Related]
9. Effect of montelukast on peripheral airflow obstruction in children with asthma.
Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
[TBL] [Abstract][Full Text] [Related]
10. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
[TBL] [Abstract][Full Text] [Related]
11. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics.
Stevenson DD; Simon RA; Mathison DA; Christiansen SC
Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):477-82. PubMed ID: 11152169
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma.
Rolla G; Di Emanuele A; Dutto L; Marsico P; Nebiolo F; Corradi F; Brussino L; Bucca C
Allergy; 2004 Aug; 59(8):827-32. PubMed ID: 15230814
[TBL] [Abstract][Full Text] [Related]
13. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
Lee DK; Haggart K; Robb FM; Lipworth BJ
Eur Respir J; 2004 Aug; 24(2):226-30. PubMed ID: 15332389
[TBL] [Abstract][Full Text] [Related]
14. Effect of montelukast on time-course of exhaled nitric oxide in asthma: influence of LTC4 synthase A(-444)C polymorphism.
Whelan GJ; Blake K; Kissoon N; Duckworth LJ; Wang J; Sylvester JE; Lima JJ
Pediatr Pulmonol; 2003 Nov; 36(5):413-20. PubMed ID: 14520724
[TBL] [Abstract][Full Text] [Related]
15. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
Stelmach I; Majak P; Jerzynska J; Stelmach W; Kuna P
Pediatr Allergy Immunol; 2004 Aug; 15(4):359-64. PubMed ID: 15305946
[TBL] [Abstract][Full Text] [Related]
18. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study).
Nieto A; Pamies R; Oliver F; Medina A; Caballero L; Mazon A
Respir Med; 2006 Jul; 100(7):1180-5. PubMed ID: 16330196
[TBL] [Abstract][Full Text] [Related]
19. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
20. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
Micheletto C; Visconti M; Tognella S; Facchini FM; Dal Negro RW
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
